Edwards Lifesciences

Selected news for the company - Edwards Lifesciences, collected since 10/2017. Recent stories appear in ridgwayrecord.com and The Markets Daily. This company shares news with Medical Research, Medtronic, Boston Scientific, Jennison Associates, Thermo Fisher and over a hundred others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
1/20/2021 The Ridgway Record ridgwayrecord.com ... using SWOT analysis. This gives a complete analysis of drivers, restraints, and opportunities of the market. This MarketTop Key Players in the Global Thrombectomy Devices Market: Argon Medical Devices Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Penumbra Inc., Koninklijke Philips NV (Spectranetics), Terumo Corporation, Straub Medical AG, Stryker CorporationGet a Sample Copy of the Report:https://www.marketinsightsreports.com/reports/07202153164/thrombectomy-devices-market-growth-trends ...
1/20/2021 Edwards Lifesciences (EW) Scheduled to Post Earnings on Wednesday The Markets Daily Edwards Lifesciences (EW) Scheduled to Post Earnings on Wednesday Posted by Kim Johansen on Jan 20th, 2021 // Comments offEdwards Lifesciences (NYSE:EW) will release its earnings data after the market closes on Wednesday, January 27th. Analysts expect Edwards Lifesciences to post earnings of $0.53 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link .Edwards Lifesciences (NYSE ...
1/19/2021 Brokerages Expect Edwards Lifesciences Co. (NYSE:EW) to Post $0.53 EPS The Markets Daily Brokerages Expect Edwards Lifesciences Co. (NYSE:EW) to Post $0.53 EPS Posted by Danessa Lincoln on Jan 19th, 2021 // Comments offWall Street brokerages expect Edwards Lifesciences Co. (NYSE:EW) to post $0.53 earnings per share for the current fiscal quarter, according to Zacks . Nine analysts have issued estimates for Edwards Lifesciences’ earnings, with the lowest EPS estimate coming in at $0.45 and the highest estimate coming in at ...
1/19/2021 Analysts Anticipate Edwards Lifesciences Co. (NYSE:EW) to Post $0.53 EPS wkrb13.com Wall Street brokerages expect Edwards Lifesciences Co. (NYSE:EW) to post $0.53 earnings per share for the current quarter, according to Zacks . Nine analysts have issued estimates for Edwards Lifesciences’ earnings, with estimates ranging from $0.45 to $0.55. Edwards Lifesciences reported earnings per share of $0.49 in the same quarter last year, which suggests a positive year over year growth rate of 8.2%. The company is expected to announce ...
1/19/2021 Canaccord Genuity Believes Neuronetics (STIM) Won’t Stop Here markets.co ... Plovanic is a 4-star analyst with an average return of 5.5% and a 54.4% success rate. Plovanic covers the Healthcare sector, focusing on stocks such as Staar Surgical Company, Merit Medical Systems, and Edwards Lifesciences .Currently, the analyst consensus on Neuronetics is a Strong Buy with an average price target of $17.25, representing a 18.8% upside. In a report issued on January 8, JMP Securities also maintained a Buy ...
1/19/2021 Analysts’ Top Healthcare Picks: Nevro Crop (NVRO), Biohaven Pharmaceutical Holding Co (BHVN) markets.co ... Plovanic is a 4-star analyst with an average return of 5.5% and a 54.4% success rate. Plovanic covers the Healthcare sector, focusing on stocks such as Staar Surgical Company, Merit Medical Systems, and Edwards Lifesciences .The word on The Street in general, suggests a Strong Buy analyst consensus rating for Nevro Crop with a $201.43 average price target, representing a 15.1% upside. In a report issued on January 4 ...
1/19/2021 Medical Devices Market Size, Status and Forecast 2020-2026: Medtronic, GE Healthcare, Abbott, Baxter sbwire.com ... Johnson, GE Healthcare, Abbott, Siemens Healthineers, Philips Health, Stryker, Becton Dickinson, Boston Scientific, Danaher, Zimmer Biomet, Essilor, Novartis, 3M Health Care, B. Braun, Olympus, Terumo, Baxter, Smith & Nephew, Dentsply Sirona, Varian Medical Systems, Getinge & Edwards Lifesciences What's keeping Medtronic, Johnson & Johnson, GE Healthcare, Abbott, Siemens Healthineers, Philips Health, Stryker, Becton Dickinson, Boston Scientific, Danaher, Zimmer Biomet, Essilor, Novartis, 3M Health Care, B. Braun, Olympus, Terumo, Baxter, Smith & Nephew, Dentsply Sirona ...
1/18/2021 Insider Selling: Edwards Lifesciences Co. (NYSE:EW) CEO Sells $5,998,125.00 in Stock wkrb13.com ... moving average of $87.28 and a 200-day simple moving average of $80.95. The company has a current ratio of 3.52, a quick ratio of 2.61 and a debt-to-equity ratio of 0.14. Edwards Lifesciences Co. has a twelve month low of $51.51 and a twelve month high of $92.08.Get Edwards Lifesciences alerts: Edwards Lifesciences (NYSE:EW) last posted its earnings results on Wednesday, October 21st. The medical ...
1/18/2021 Chapman-UC Irvine Tech Innovation Index for Orange County mynews13.com ... Orange County to being a major tech and innovation hub. But Palmer Lucky founded the virtual reality company Oculus in Irvine, semiconductor company Broadcom got its footing here, and so did Blizzard Entertainment and Edwards Lifesciences , and more.What You Need To Know Unbeknownst to many, Orange County has a strong history as a tech and innovation hubNew Chapman-UC Irvine Innovation Index shows, in the past two years ...
1/17/2021 Gofen & Glossberg LLC IL Has $763,000 Position in Edwards Lifesciences Co. (NYSE:EW) rivertonroll.com Gofen & Glossberg LLC IL Has $763,000 Position in Edwards Lifesciences Co. (NYSE:EW) Posted by Rob Hiaasen on Jan 17th, 2021 TweetGofen & Glossberg LLC IL lessened its holdings in Edwards Lifesciences Co. (NYSE:EW) by 6.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 8,360 shares of the medical research company’s stock after selling 586 ...
1/16/2021 2,458 Shares in Edwards Lifesciences Co. (NYSE:EW) Purchased by Rowland Carmichael Advisors Inc. ADV Ticker Report Rowland Carmichael Advisors Inc. ADV acquired a new position in Edwards Lifesciences Co. (NYSE:EW) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 2,458 shares of the medical research company’s stock, valued at approximately $224,000.A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. FMR LLC increased its holdings in Edwards Lifesciences by 97.2 ...
1/15/2021 Portland Hill Asset Management Ltd Purchases Shares of 898 Edwards Lifesciences Co. (NYSE:EW) zolmax.com Portland Hill Asset Management Ltd Purchases Shares of 898 Edwards Lifesciences Co. (NYSE:EW) Posted by John Perry on Jan 15th, 2021 TweetPortland Hill Asset Management Ltd purchased a new stake in Edwards Lifesciences Co. (NYSE:EW) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 898 shares of the medical research company’s stock, valued at ...
1/15/2021 Hemodynamic Monitoring Systems Market Expected to Witness High Growth by 2027 prsync.com Edwards Lifesciences Corporation Osypka Medical GmbHThe Hemodynamic Monitoring Systems Market Company Profiles are individually represented for all major participants and indices such as Financial Performance, Strategic Initiatives, Product Portfolio & Company Overview.Company Overview:Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.Financial ...
1/14/2021 IFM Investors Pty Ltd Increases Position in Edwards Lifesciences Co. (NYSE:EW) The Markets Daily IFM Investors Pty Ltd Increases Position in Edwards Lifesciences Co. (NYSE:EW) Posted by Kim Johansen on Jan 14th, 2021 // Comments offIFM Investors Pty Ltd boosted its position in shares of Edwards Lifesciences Co. (NYSE:EW) by 17.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 60,019 shares of the medical research company’s stock after acquiring an additional 8,834 shares during the quarter. IFM Investors Pty Ltd ...
1/13/2021 Jacobs & Co. CA Decreases Holdings in Edwards Lifesciences Co. (NYSE:EW) zolmax.com Jacobs & Co. CA Decreases Holdings in Edwards Lifesciences Co. (NYSE:EW) Posted by Tammy Falkenburg on Jan 12th, 2021 TweetJacobs & Co. CA decreased its position in Edwards Lifesciences Co. (NYSE:EW) by 0.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 114,742 shares of the medical research company’s stock after selling 261 shares during the quarter. Edwards Lifesciences comprises 1.4% of Jacobs & Co. CA’s holdings ...
1/13/2021 BTIG Believes Neuronetics (STIM) Still Has Room to Grow markets.co ... Thibault is a 5-star analyst with an average return of 69.7% and a 71.0% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Edwards Lifesciences .The word on The Street in general, suggests a Strong Buy analyst consensus rating for Neuronetics with a $11.50 average price target, which is a -4.0% downside from current levels. In a report issued ...
1/13/2021 Abner Herrman & Brock LLC Decreases Stake in Edwards Lifesciences Co. (NYSE:EW) theenterpriseleader.com Abner Herrman & Brock LLC Decreases Stake in Edwards Lifesciences Co. (NYSE:EW) Posted by Martin Roberts on Jan 12th, 2021Abner Herrman & Brock LLC trimmed its holdings in shares of Edwards Lifesciences Co. (NYSE:EW) by 16.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 67,671 shares of the medical research company’s stock after selling 13,284 ...
1/13/2021 Abner Herrman & Brock LLC Lowers Holdings in Edwards Lifesciences Co. (NYSE:EW) thelincolnianonline.com Abner Herrman & Brock LLC Lowers Holdings in Edwards Lifesciences Co. (NYSE:EW) Posted by Stephan Jacobs on Jan 12th, 2021 TweetAbner Herrman & Brock LLC lowered its holdings in Edwards Lifesciences Co. (NYSE:EW) by 16.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 67,671 shares of the medical research company’s stock after selling 13,284 shares during the period. Abner ...
1/13/2021 Eargo (NASDAQ:EAR) and Edwards Lifesciences (NYSE:EW) Head to Head Comparison zolmax.com Edwards Lifesciences has higher revenue and earnings than Eargo.SummaryEdwards Lifesciences beats Eargo on 8 of the 9 factors compared between the two stocks.About Edwards LifesciencesEdwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve ...
1/13/2021 Bremer Bank National Association Sells 513 Shares of Edwards Lifesciences Co. (NYSE:EW) theenterpriseleader.com Bremer Bank National Association Sells 513 Shares of Edwards Lifesciences Co. (NYSE:EW) Posted by Liza Goodheart on Jan 13th, 2021Bremer Bank National Association lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW) by 10.1% during the 4th quarter, Holdings Channel.com reports. The fund owned 4,570 shares of the medical research company’s stock after selling 513 shares during the quarter. Bremer Bank National Association’s holdings ...